Skip to main content

Table 2 Modeling diagnostic of the metabolic data derived from plasma samples of various time points after GalN/LPS treatment

From: A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice

PLS model

Components

Modeling diagnostic

  

R2X

R2Y

Q2Y

4 h

1

0.186

0.288

0.225

 

2

0.256

0.412

0.368

 

3

0.335

0.556

0.406

5 h

1

0.351

0.742

0.701

 

2

0.471

0.876

0.812

 

3

0.504

0.915

0.857

6 h

1

0.367

0.781

0.666

 

2

0.433

0.896

0.817

 

3

0.493

0.941

0.862

  1. Note. 1, 2, or 3 indicates quantities of components contributed to cumulative values. R2X is the fraction of X-variation; R2Y is the fraction of Y-variation; Q2Y is the cumulated cross-validation for R2Y. R2X, R2Y and Q2Y are all ranged from 0 to 1.